Ignite Creation Date:
2024-05-05 @ 7:31 PM
Last Modification Date:
2024-10-26 @ 9:50 AM
Study NCT ID:
NCT00686777
Status:
COMPLETED
Last Update Posted:
2017-04-07
First Post:
2008-05-27
Brief Title:
Pegylated Interferon PEG-IFN Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight Study P05172COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hepatitis C Chronic |
Keywords:
| Name | View |
|---|---|
| hepatitis C | View |